{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-032916","form_type":"8-K","ticker":"GDST","cik":"0001858007","company_name":"Goldenstone Acquisition Ltd.","filed_at":"2026-03-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.578678+00:00","generated_at":"2026-05-15T09:24:20.187254+00:00","sec_items":["5.03","5.07","8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Goldenstone Acquisition shareholders approve extension; 95% of public shares redeemed","bullets":["Approved extension of business combination deadline to December 21, 2026, with monthly $1,500 trust deposits.","Approved removal of restriction on China-based business combinations and name change to Chi Special Acquisition Company.","422,840 shares tendered for redemption; only 20,156 public shares remain outstanding.","Nearly all public shares redeemed, indicating severe lack of investor confidence in deal prospects."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-032916","json":"https://secwatch.observer/filing/0001213900-26-032916.json","markdown":"https://secwatch.observer/filing/0001213900-26-032916.md","text":"https://secwatch.observer/filing/0001213900-26-032916.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1858007/000121390026032916/0001213900-26-032916-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1858007/000121390026032916/ea0283038-8k_golden.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T09:24:20.187254+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"36b7f24f1f4d0e01ede6d6aa0a93ed7e423119c7","claim":"Goldenstone Acquisition Ltd.: Approved amendment to change company name to Chi Special Acquisition Company (effective 2026-03-23).","evidence_excerpt":"The Company’s stockholders approved a proposal to amend the Company’s Charter to change the name of the Company to “Chi Special Acquisition Company”","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1858007/000121390026032916/0001213900-26-032916-index.htm","confidence":0.9},{"claim_id":"abfdc2ae92c61981faba8a02a0fd69acb678375b","claim":"Goldenstone Acquisition Ltd.: Approved amendment to remove restriction on business combinations with entities based in China (effective 2026-03-23).","evidence_excerpt":"The Company’s stockholders approved a proposal to amend the Company’s Charter to remove the restriction on the Company’s ability to undertake an initial business combination with any entity or business based in, or with its principal or a majority of its business operations (either directly or through any subsidiaries) in, the People’s Republic of China (including Hong Kong or Macau)","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1858007/000121390026032916/0001213900-26-032916-index.htm","confidence":0.9},{"claim_id":"ddc91e5822b5c487c889bf2ec46c9022428be0c9","claim":"Goldenstone Acquisition Ltd.: Approved amendment to extend date to consummate business combination to December 21, 2026 (effective 2026-03-23).","evidence_excerpt":"The Company’s stockholders approved a proposal to amend the Company’s amended and restated certificate of incorporation, as amended, to extend the date by which the Company has to consummate a business combination until December 21, 2026","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1858007/000121390026032916/0001213900-26-032916-index.htm","confidence":0.9}],"comparable_filings":[{"accession":"0001213900-26-051018","ticker":"DMAA","company_name":"Drugs Made In America Acquisition Corp.","filed_at":"2026-05-01T23:59:59+00:00","headline":"SPAC DMAA shareholders approve extension to April 2027; ~28% of shares redeemed for $99.3M","event_type":"other_material","sec_items":["5.03","5.07","8.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 5.07, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-051018","json":"https://secwatch.observer/filing/0001213900-26-051018.json","markdown":"https://secwatch.observer/filing/0001213900-26-051018.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2028614/000121390026051018/0001213900-26-051018-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2028614/000121390026051018/ea0288774-8k_drugs.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"The Company’s stockholders approved a proposal to amend the Company’s Charter to change the name of the Company to “Chi Special Acquisition Company”","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1858007/000121390026032916/0001213900-26-032916-index.htm","comparable_excerpt":"to amend the Company’s Second Amended and Restated Memorandum and Articles of Association (the “ Existing Charter ”) by adopting an amendment to the Existing Charter in the form set forth in Annex A to the Proxy Statement (the “ Extension Amendment ”) which reflects the extension of the date by which the Company must consummate a business combination (the “ Combination Period ”) up to twelve (12) times from April 29, 2026 (the “ Termination Date ”) to April 29, 2027, each by an additional one (1) month","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2028614/000121390026051018/0001213900-26-051018-index.htm"}},{"accession":"0001703056-26-000078","ticker":"ADT","company_name":"ADT Inc.","filed_at":"2026-05-08T23:59:59+00:00","headline":"Apollo sells all 102M ADT shares; ADT repurchases 29.1M shares in $1.5B plan","event_type":"other_material","sec_items":["5.02","5.03","8.01","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001703056-26-000078","json":"https://secwatch.observer/filing/0001703056-26-000078.json","markdown":"https://secwatch.observer/filing/0001703056-26-000078.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1703056/000170305626000078/0001703056-26-000078-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1703056/000170305626000078/adt-20260504.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"The Company’s stockholders approved a proposal to amend the Company’s Charter to change the name of the Company to “Chi Special Acquisition Company”","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1858007/000121390026032916/0001213900-26-032916-index.htm","comparable_excerpt":"On May 8, 2026, the Board approved an amendment and restatement of the Company’s Amended and Restated Bylaws, dated as of September 15, 2023 (as amended, the “ Bylaws ”), to remove references related to Apollo and the Amended and Restated Stockholders Agreement, dated December 14, 2018, between the Company, Prime Security Services TopCo Parent, L.P., and the Co-Investors.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1703056/000170305626000078/0001703056-26-000078-index.htm"}},{"accession":"0001829126-26-004565","ticker":"MCAH","company_name":"Mountain Crest Acquisition 6 Corp.","filed_at":"2026-05-05T23:59:59+00:00","headline":"Mountain Crest Acquisition 6 Corp. closes $60M IPO; units start trading April 30","event_type":"other_material","sec_items":["1.01","3.02","5.03","8.01","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-26-004565","json":"https://secwatch.observer/filing/0001829126-26-004565.json","markdown":"https://secwatch.observer/filing/0001829126-26-004565.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2109876/000182912626004565/0001829126-26-004565-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2109876/000182912626004565/mountaincrest6_8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"The Company’s stockholders approved a proposal to amend the Company’s Charter to change the name of the Company to “Chi Special Acquisition Company”","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1858007/000121390026032916/0001213900-26-032916-index.htm","comparable_excerpt":"On April 29, 2026, in connection with the IPO, the Company filed its Amended and Restated Memorandum and Articles of Association, as described in the Registration Statement, with the Registry of Corporate Affairs of British Virgin Islands.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2109876/000182912626004565/0001829126-26-004565-index.htm"}},{"accession":"0001193125-26-203988","ticker":"COAG","company_name":"Hemab Therapeutics Holdings, Inc.","filed_at":"2026-05-04T23:59:59+00:00","headline":"Hemab Therapeutics completes IPO of 19.3M shares at $18.00, raising $346.7M","event_type":"other_material","sec_items":["5.03","8.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-203988","json":"https://secwatch.observer/filing/0001193125-26-203988.json","markdown":"https://secwatch.observer/filing/0001193125-26-203988.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2114044/000119312526203988/0001193125-26-203988-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2114044/000119312526203988/d149100d8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"The Company’s stockholders approved a proposal to amend the Company’s Charter to change the name of the Company to “Chi Special Acquisition Company”","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1858007/000121390026032916/0001213900-26-032916-index.htm","comparable_excerpt":"On May 4, 2026, Hemab Therapeutics Holdings, Inc. (the “Company”) filed a restated certificate of incorporation (the “Restated Certificate”) with the Secretary of State of the State of Delaware in connection with the closing of the Company’s initial public offering of common stock (the “IPO”).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2114044/000119312526203988/0001193125-26-203988-index.htm"}},{"accession":"0001193125-26-201578","ticker":"RREV","company_name":"RRE Ventures Acquisition Corp.","filed_at":"2026-05-01T23:59:59+00:00","headline":"RRE Ventures Acquisition Corp. prices and closes $250M IPO; units begin trading on Nasdaq","event_type":"other_material","sec_items":["1.01","3.02","5.02","5.03","8.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-201578","json":"https://secwatch.observer/filing/0001193125-26-201578.json","markdown":"https://secwatch.observer/filing/0001193125-26-201578.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2123969/000119312526201578/0001193125-26-201578-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2123969/000119312526201578/d77496d8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"The Company’s stockholders approved a proposal to amend the Company’s Charter to change the name of the Company to “Chi Special Acquisition Company”","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1858007/000121390026032916/0001213900-26-032916-index.htm","comparable_excerpt":"On April 28, 2026, in connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the “ Amended and Restated Memorandum and Articles of Association ”) with the Cayman Islands Registrar of Companies, which was effective on April 29, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2123969/000119312526201578/0001193125-26-201578-index.htm"}},{"accession":"0001062822-26-000065","ticker":"LXRX","company_name":"LEXICON PHARMACEUTICALS, INC.","filed_at":"2026-04-30T23:59:59+00:00","headline":"Lexicon doubles authorized shares to 900M, adopts expanded 2026 equity plans","event_type":"other_material","sec_items":["3.02","5.02","5.03","5.07","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 5.07, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001062822-26-000065","json":"https://secwatch.observer/filing/0001062822-26-000065.json","markdown":"https://secwatch.observer/filing/0001062822-26-000065.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000065/0001062822-26-000065-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000065/lxrx-20260430.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"The Company’s stockholders approved a proposal to amend the Company’s Charter to change the name of the Company to “Chi Special Acquisition Company”","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1858007/000121390026032916/0001213900-26-032916-index.htm","comparable_excerpt":"The Seventh Amended and Restated Certificate of Incorporation increases the number of shares of our authorized Common Stock from 450,000,000 to 900,000,000.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000065/0001062822-26-000065-index.htm"}},{"accession":"0001649739-26-000020","ticker":"BAFN","company_name":"BayFirst Financial Corp.","filed_at":"2026-04-30T23:59:59+00:00","headline":"BayFirst raises $80M in PIPE, reports Q1 loss of $5.7M, names new bank CEO","event_type":"other_material","sec_items":["1.01","3.02","5.03","2.02","5.02","7.01","8.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001649739-26-000020","json":"https://secwatch.observer/filing/0001649739-26-000020.json","markdown":"https://secwatch.observer/filing/0001649739-26-000020.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1649739/000164973926000020/0001649739-26-000020-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1649739/000164973926000020/bafn-20260428.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"The Company’s stockholders approved a proposal to amend the Company’s Charter to change the name of the Company to “Chi Special Acquisition Company”","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1858007/000121390026032916/0001213900-26-032916-index.htm","comparable_excerpt":"On April 28, 2026, the Company filed Articles of Amendment to its Articles of Incorporation with the Florida Division of Corporations creating and authorizing 4,000 shares of Series D Preferred Stock and 4,000 shares of Series E Preferred Stock.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1649739/000164973926000020/0001649739-26-000020-index.htm"}},{"accession":"0001104659-26-057915","ticker":"SUJA","company_name":"SUJA LIFE, INC.","filed_at":"2026-05-08T23:59:59+00:00","headline":"Suja Life completes IPO of 8.9M shares at $21/share; closes May 8, 2026","event_type":"other_material","sec_items":["1.01","3.02","3.03","5.03","5.02","9.01"],"materiality_score":0.9,"calibrated_materiality_score":0.9,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-057915","json":"https://secwatch.observer/filing/0001104659-26-057915.json","markdown":"https://secwatch.observer/filing/0001104659-26-057915.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1934114/000110465926057915/0001104659-26-057915-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1934114/000110465926057915/tm2530822d27_8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"The Company’s stockholders approved a proposal to amend the Company’s Charter to change the name of the Company to “Chi Special Acquisition Company”","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1858007/000121390026032916/0001213900-26-032916-index.htm","comparable_excerpt":"On May 7, 2026, the Company filed an amended and restated certificate of incorporation (the “Certificate of Incorporation”) with the Secretary of State of the State of Delaware","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1934114/000110465926057915/0001104659-26-057915-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}